We compared the performance of four assays for detection of hepatitis
B virus (HBV) DNA: the PCR; the branched DNA hybridization assay (Chir
on); and two hybridization assays that use liquid hybridization (Abbot
t) or direct membrane hybridization (MH). Testing 109 random hepatitis
B surface antigen-positive patient samples, the percentages found to
be HBV DNA positive among 30 hepatitis B e antigen (HBeAg)-positive sa
mples and 79 HBeAg-negative samples were as follows: PCR, 100 and 90%;
Chiron, 73 and 25%; Abbott, 67 and 13%; and MH, 40 and 8%. In six hep
atitis B surface antigen-positive, HBeAg-negative samples, all three h
ybridization assays detected HBV DNA. Testing dilutions prepared from
the Eurohep HBV DNA standards, the detection limits of the assays appe
ared to be the following: PCR, 2.5 x 10(2) HBV genomes per ml; Chiron,
2.5 x 10(6) genomes per ml; and Abbott and MH, 2.5 x 10(7) genomes pe
r ml. HBV DNA levels in the dilution series, as reported by the Chiron
and MH assays, were, on average, 2 times higher than calculated; the
Abbott results were, on average, 19 times lower than calculated. We co
ncluded that high levels of HBV DNA and the presence of HBeAg do not n
ecessarily coincide, that the application of hybridization assays is l
imited to the monitoring of relatively high levels of HBV DNA, and tha
t further standardization of quantitative HBV DNA assays is necessary
to facilitate comparison of HBV DNA levels.